We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$39.5B
AUM Growth
+$59.4M
Cap. Flow
-$2.29B
Cap. Flow %
-5.81%
Top 10 Hldgs %
11.01%
Holding
1,026
New
121
Increased
328
Reduced
359
Closed
133

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$338M
2
UNH icon
UnitedHealth
UNH
+$140M
3
XOM icon
ExxonMobil
XOM
+$134M
4
ATVI
Activision Blizzard
ATVI
+$122M
5
VZ icon
Verizon
VZ
+$118M

Sector Composition

Rank Sector Weight
1 Financials 15.07%
2 Healthcare 14.16%
3 Technology 13.06%
4 Industrials 12.52%
5 Consumer Discretionary 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
301
Viatris
VTRS
$20.8B
$39.7M 0.1%
669,677
-107,443
-14% -$6.13M
ILMN icon
302
Illumina
ILMN
$29B
$39.7M 0.1%
219,861
+1,715
+0.8% +$323K
LRCX icon
303
Lam Research
LRCX
$316B
$39.7M 0.1%
5,646,220
-1,864,290
-25% -$14.7M
ROST icon
304
Ross Stores
ROST
$80.8B
$39.6M 0.1%
751,106
-3,272
-0.4% -$162K
GEN icon
305
Gen Digital
GEN
$16.6B
$39.4M 0.1%
1,687,700
+1,284,400
+318% +$32.1M
NSC icon
306
Norfolk Southern
NSC
$75.4B
$39.4M 0.1%
382,730
+5,300
+1% +$567K
COST icon
307
Costco
COST
$434B
$39.3M 0.1%
259,276
+109,884
+74% +$16.1M
JNS
308
DELISTED
Janus Capital Group Inc
JNS
$39.3M 0.1%
2,283,396
-844,830
-27% -$14.4M
THG icon
309
Hanover Insurance
THG
$8.18B
$39.2M 0.1%
+540,389
New +$38.3M
NBIX icon
310
Neurocrine Biosciences
NBIX
$18.2B
$39.2M 0.1%
987,584
+753,717
+322% +$27M
HAIN icon
311
Hain Celestial
HAIN
$45.1M
$39.1M 0.1%
611,125
-666,323
-52% -$39.4M
RARE icon
312
Ultragenyx Pharmaceutical
RARE
$2.49B
$39M 0.1%
628,332
+200,916
+47% +$11.2M
ACM icon
313
Aecom
ACM
$9.39B
$39M 0.1%
+1,264,823
New +$36.1M
SITC icon
314
SITE Centers
SITC
$234M
$38.9M 0.1%
1,623,153
-690,799
-30% -$17M
UHS icon
315
Universal Health Services
UHS
$10.2B
$38.9M 0.1%
330,525
-77,365
-19% -$8.56M
DIS icon
316
Walt Disney
DIS
$171B
$38.9M 0.1%
370,594
+5,097
+1% +$514K
ZEN
317
DELISTED
ZENDESK INC
ZEN
$38.7M 0.1%
1,704,287
+1,042,806
+158% +$25M
CYBR
318
DELISTED
CyberArk
CYBR
$38.5M 0.1%
+692,850
New +$32.7M
RKUS
319
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$38.4M 0.1%
2,984,874
+1,878
+0.1% +$21K
OPLN
320
Openlane
OPLN
$4.31B
$38.1M 0.1%
2,652,288
+972,980
+58% +$13.2M
GEVA
321
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$37.9M 0.1%
388,980
-44,062
-10% -$4.66M
CSTE icon
322
Caesarstone
CSTE
$70.5M
$37.7M 0.1%
621,037
+353,392
+132% +$21.8M
PLD icon
323
Prologis
PLD
$135B
$37.7M 0.1%
865,000
+17,000
+2% +$745K
CRUS icon
324
Cirrus Logic
CRUS
$6.66B
$37.7M 0.1%
+1,132,594
New +$32.9M
MDVN
325
DELISTED
MEDIVATION, INC.
MDVN
$37.2M 0.09%
576,900
-246,218
-30% -$14.1M

Similar funds

Lord, Abbett & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Lord, Abbett & Co held 1,026 positions worth $39.5B, up 0.15% from $39.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Lord, Abbett & Co withdrew a net $2.29B in Q1 2015, closing 133 positions and reducing 359 holdings. Its most notable exit was POLYPORE INTERNATIONAL, INC, an estimated $85M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Lord, Abbett & Co opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $76.9M.

  • Lord, Abbett & Co's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 75,968 shares worth $76.9M.
  • Lord, Abbett & Co added most to Pfizer in Q1 2015, an estimated $338M increase.
  • Lord, Abbett & Co's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $274M.
  • Lord, Abbett & Co fully exited POLYPORE INTERNATIONAL, INC in Q1 2015, selling an estimated $85M.
  • Lord, Abbett & Co's ten largest holdings make up 11% of its $39.5B portfolio in Q1 2015.
  • Lord, Abbett & Co opened 121 new positions and closed 133 in Q1 2015.
  • Lord, Abbett & Co's portfolio value rose 0.15% quarter-over-quarter to $39.5B.

Based on Lord, Abbett & Co's 13F filing for Q1 2015, filed 15 May 2015.